Eur Rev Med Pharmacol Sci 2020; 24 (2): 813-820
DOI: 10.26355/eurrev_202001_20064

Atypical presentation of acute pancreatitis: a single center case-match analysis of clinical outcomes

M. Covino, G. Quero, V. Ojetti, C. Cina, F. Galiandro, F. Longo, E. Torelli, C. Fiorillo, R. Menghi, B. Simeoni, F. Franceschi, S. Alfieri

Medicina d’Urgenza – Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. giuseppequero@yahoo.it


OBJECTIVE: Acute pancreatitis (AP) may present an aspecific clinical picture without abdominal symptoms (atypical AP). We compared clinical outcomes between typical and atypical AP.
PATIENTS AND METHODS: Thirty out of 1163 patients (2.6%) presented an atypical AP. Demographic, clinical data, laboratory and radiological findings, management type, length of hospital stay (LOS) and mortality rate were retrospectively reviewed. A case match analysis 2:1 was performed. The final groups comprised 50 typical APs (TAP group) and 25 atypical APs (AAP group).
RESULTS: The AAP patients presented fever (36%), syncope (32%) and dyspnea (16%) as the most frequent symptoms. Laboratory values showed similarity between the two groups. We noted a comparable edematous AP rate in both groups (p=0.36). Ten (20%) TAP and 3 (12%) AAP patients needed ERCP, respectively (p=0.38). Cholecystectomy was similarly performed in both cohorts (p=0.81). One TAP patient underwent a percutaneous drainage and subsequent surgical necrosectomy compared to none in the AAP cohort (p=0.47). LOS and mortality rate were comparable (p=0.76 and 0.3, respectively).
CONCLUSIONS: Similar outcomes have been reached in the two groups. Routine evaluation of the serum amylase values fundamentally contributed to early diagnosis and appropriate treatment.

Free PDF Download

To cite this article

M. Covino, G. Quero, V. Ojetti, C. Cina, F. Galiandro, F. Longo, E. Torelli, C. Fiorillo, R. Menghi, B. Simeoni, F. Franceschi, S. Alfieri
Atypical presentation of acute pancreatitis: a single center case-match analysis of clinical outcomes

Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 2
Pages: 813-820
DOI: 10.26355/eurrev_202001_20064